Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting [Corrigendum]
Senbel E, Tropé S, Herman-Demars H, et al. Patient Prefer Adherence. 2021;15:751–760. Page 751, Abstract, Results section, the text “Switch to SC route increased the proportion of patients with remission or LDA from 22.8% to 52.9% and increased quality of life even in...
Main Authors: | Senbel E, Tropé S, Herman-Demars H, Zinovieva E, Courbeyrette A, Clerson P, Fardini Y, Flipo RM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-07-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/corrigendum-benefits-of-switch-from-oral-to-subcutaneous-route-on-adhe-peer-reviewed-fulltext-article-PPA |
Similar Items
-
Use of Auto-Injector for Methotrexate Subcutaneous Self-Injections: High Satisfaction Level and Good Compliance in SELF-I Study, a Randomized, Open-Label, Parallel Group Study
by: Alain Saraux, et al.
Published: (2018-12-01) -
SAFETY OF USING METHOTREXATE SOLUTION FOR SUBCUTANEOUS INJECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev, et al.
Published: (2015-09-01) -
The reaction of the skin and its appendages in rheumatoid arthritis patients using subcutaneous methotrexate: A description of three cases
by: Yu. V. Muravyev, et al.
Published: (2016-10-01) -
TWELVE-WEEK MULTICENTER OPEN-LABEL RANDOMIZED COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF METHOTREXATE AS A CONCENTRATED SOLUTION FOR SUBCUTANEOUS ADMINISTRATION AND AS 15-MG TABLETS PER WEEK FOR RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev, et al.
Published: (2016-07-01) -
The use of subcutaneous methotrexate from various manufacturers in real clinical practice: a comparative study
by: D. E. Karateev, et al.
Published: (2019-11-01)